For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Visible Genetics Inc.

USPTO Granted Patents = 60

% Expired Patents = 1.7

Forward Citations = 1,634

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

James M Dunn (26 out of 27 patents)

John K Stevens (21 out of 29 patents)

Alexandre M Izmailov (12 out of 27 patents)

4. John A Renfrew (12 out of 12 patents)

5. Paul Waterhouse (11 out of 14 patents)

6. James Leushner (10 out of 10 patents)

7. Jean-Michel Lacroix (8 out of 9 patents)

8. May Hui (8 out of 8 patents)

9. Marina T Larson (8 out of 8 patents)

10. Rodney D Gilchrist (7 out of 7 patents)

11. Henryk Zaleski (7 out of 8 patents)

12. Thomas D Yager (5 out of 5 patents)

13. Vrijmoed Chi (4 out of 4 patents)

14. James W Cassidy (4 out of 4 patents)

15. Bruno C Maruzzo (3 out of 5 patents)

Core Competencies:

DNA Sequencing

Electrophoresis

Mutation Detection

Nucleic Acids

HIV Mutations

Genotyping

BRCA1 Gene

p53 Screening

Automated Systems

Micro-Electrophoresis

Isothermal Sequencing

Fluorescence Detection

60 patents: Sort by Forward Citations

1. 6653107 - Method and kit for evaluation of HIV mutations (2003-11-25),

2. 6582577 - Electrophoresis gel cassette (2003-06-24),

3. 6554987 - Method and apparatus for alignment of signals for use in DNA base-calling (2003-04-29),

4. 6503704 - Method, reagent and kit for genotyping human papilloma virus (2003-01-07),

5. 6440664 - Apparatus for sequencing of nucleic acids using multiple dyes (2002-08-27),

6. 6436641 - Method and apparatus for DNA sequencing (2002-08-20),

7. 6432634 - Method, apparatus and kits for sequencing of nucleic acids using multiple dyes (2002-08-13),

8. 6413718 - Method for sequencing of nucleic acid polymers (2002-07-02),

9. 6404907 - Method for sequencing nucleic acids with reduced errors (2002-06-11),

10. 6403303 - Method and reagents for testing for mutations in the BRCA1 gene (2002-06-11),

11. 6397150 - Method and apparatus for sequencing of DNA using an internal calibrant (2002-05-28),

12. 6303303 - Method and system for DNA sequence determination and mutation detection (2001-10-16),

13. 6270963 - Method for testing for mutations in DNA from a patient sample (2001-08-07),

14. 6265152 - Method and kit for evaluation of HIV mutations (2001-07-24),

15. 6261430 - Micro-electrophoresis chip for moving and separating nucleic acids and other charged molecules (2001-07-17),

Visible Genetics Inc., based in Toronto, Canada, specializes in advanced DNA sequencing technologies. The company focuses on developing innovative solutions for mutation detection and genotyping, particularly in the context of critical health issues such as HIV mutations and hereditary cancers. Their expertise extends to the analysis of nucleic acids, including significant genes like BRCA1 and p53, contributing to personalized medicine and improved diagnostic capabilities in the field of genetics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

60 Patents

#23 in Toronto

#230 in Canada

#12,077 in the World

Toronto, Canada

Visible Genetics Inc.

Forward Citations = 1,634

33 inventors:

James M Dunn (26 out of 27 patents)

John K Stevens (21 out of 29 patents)

Alexandre M Izmailov (12 out of 27 patents)

4. John A Renfrew (12 out of 12 patents)

5. Paul Waterhouse (11 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…